An observational study in Cardiac Arrest With Successful Resuscitation and Cardiac Arrest, Cause Unspecified, sponsored by University Hospital Ostrava. Recruiting at 2 sites in Czechia. Open to participants aged 3 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-06-06.
Sponsored by University Hospital Ostrava · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Heart Arrest with a site in Czechia — 7 open to participants now, 8 under way, none of them phase 3. Heart Arrest · Czechia.
Among the 15 studies in Heart Arrest with a site in Czechia, this one is one of 3 that started in 2025, is one of 7 observational ones, and was the 10th registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →7 of the 15 studies in Heart Arrest with a site in Czechia are open now. Recruiting first, the newest first:
Emergency Medical Service, Prague · Sites in Czechia
Ages 18–70
University Hospital Ostrava · Sites in Czechia
Ages 18–70
University Hospital Pilsen · Sites in Czechia
Ages 18–100
University Hospital Ostrava · Sites in Czechia
Ages 18–70
General University Hospital, Prague · Sites in Czechia
Ages 18–70
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 3 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 100 is below the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 168 across the 8 interventional studies, 80 across the 7 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 15 have an industry lead sponsor. The 10 most frequent:
University Hospital Ostrava is the lead sponsor of 149 studies on the registry; 51 are open to participants now.
University Hospital Ostrava has 5 studies filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
3 of the studies in Heart Arrest with a site in Czechia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04838418University Hospital PilsenTransorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest | 2026-12-01 |
| NCT07596446Emergency Medical Service, PragueFEMART-1 Pilot Study | 2026-12-31 |
| NCT07285915University Hospital PilsenThe Role of Stress in Cardiac Arrest (Cortizol CPR) | 2027-07-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Heart Arrest with a site in Czechia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study evaluates the feasibility of implementing a mobile extracorporeal membrane oxygenation (ECMO) team and optimizing patient transport logistics.
The aim of the study is to improve neurological outcomes in out-of-hospital cardiac arrest (OHCA) cases in the Moravian-Silesian Region. By analysing regional epidemiological and demographic data, the project aims to identify key factors for reducing the time from collapse to the initiation of ECMO and to support the development of effective protocols for extracorporeal cardiopulmonary resuscitation (ECPR).
Patients indicated for ECPR after out-of-hospital cardiac arrest, for whom transport of the patient to an ECMO centre or deployment of an ECMO team is logistically manage-able.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
Procedure: Extracorporeal cardiopulmonary resuscitation (ECPR)
Extracorporeal cardiopulmonary resuscitation (commonly known as ECPR) is a method of cardiopulmonary resuscitation (CPR) that passes the patient's blood through a machine in a process to oxygenate the blood supply.
Neurological outcome after 30 days (CPC score)
Assessment of the neurological status of patients 30 days after the event using the Cerebral Performance Category (CPC) scale, which measures the extent of neurological impairment: * CPC 1 = good neurological condition * CPC 2 = mild impairment * CPC 3-5 = serious impairment, vegetative state or death The primary endpoint of the study is the proportion of patients with a favourable neurological outcome (CPC 1-2).
Time frame: 30 days
Time from collapse to initiation of ECMO
Measuring the time (in minutes) from patient collapse to ECMO initiation. The aim is to analyse how this time affects neurological outcome.
Time frame: Up to 2 hours
Transport time to the ECMO centre
Measurement of the time (in minutes) from the arrival of the Emergency Medical Services (EMS) at the scene to the admission of the patient to the ECMO centre.
Time frame: Up to 2 hours
Arrival time for the mobile ECMO team to the scene
Time interval (in minutes) from activation of the mobile ECMO team to its arrival at the scene. The aim is to evaluate the effectiveness of the model and the potential time benefit of intervention in the field.
Time frame: Up to 2 hours
Plan to share: No — There is no plan to make individual participant data available to other researchers. The data may be provided upon request.
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for May 2026, 12 months after the start.
Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 12 months is below that.
Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.